SAMD4A and breast carcinoma: Consistent with the trend of results from public databases, TSEN54 was upregulated in breast cancer cell lines and GSPT2, RNASE1, SAMD4A, and TIPARP were downregulated in breast cancer cell lines (Figure 8A-E).